Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biol Chem ; 380(6): 669-77, 1999 Jun.
Article in English | MEDLINE | ID: mdl-10430031

ABSTRACT

To study the degradation requirements of unassembled immunoglobulin (Ig) chains, we heterologously expressed a cDNA encoding the secretory form of murine mu in the yeast S. cerevisiae. We found that mu chains were translocated into and retained in the endoplasmic reticulum (ER) as they were N-glycosylated and bound to the yeast homolog of BiP, Kar2p. Similar to mutant yeast carboxypeptidase Y (CPY*), known to undergo cytosolic degradation, mu protein is stabilized in yeast mutants lacking the ubiquitinating enzymes Ubc6p and Ubc7p or in cells overexpressing mutant ubiquitin. Unexpectedly, the translation inhibitor cycloheximide (CHX), but not puromycin, led to the accumulation of polyubiquitinated mu chains that were still glycosylated. By contrast, degradation of CPY* was not impaired by CHX, indicating that the drug affects a substrate-specific degradation step. In contrast to the situation for CPY*, the ER-transmembrane protein Der1p is not essential for mu degradation. Strikingly, however, the CHX-induced accumulation of polyubiquitinated Igmu chains was stronger in deltader1-mutants as compared to wild-type cells, indicating an additive effect of two inhibitory conditions. The results support a previously unknown activity of CHX, i.e. impairing the degradation of transport-incompetent secretory mu chains. Moreover, this activity will allow to dissect substrate-specific steps in ER associated protein degradation.


Subject(s)
Cycloheximide/pharmacology , Endoplasmic Reticulum/metabolism , Biopolymers/metabolism , Carboxypeptidases/metabolism , Cathepsin A , Fungal Proteins/metabolism , Glycosylation , HSP70 Heat-Shock Proteins/metabolism , Hydrolysis , Immunoglobulin mu-Chains/genetics , Immunoglobulin mu-Chains/metabolism , Polyubiquitin , Protein Binding , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Ubiquitins/metabolism
2.
J Immunol ; 155(10): 4757-65, 1995 Nov 15.
Article in English | MEDLINE | ID: mdl-7594477

ABSTRACT

In the endoplasmic reticulum, MHC class II alpha beta dimers associate with the trimeric invariant chain (li), generating a nine-subunit (alpha beta li)3 complex. In the presence of li, the peptide binding groove is blocked, so that loading with self or antigenic peptides can only occur after proteolytic removal of li in specialized post-Golgi compartments. The class II-associated invariant chain peptide region of li (about residues 81-104) is known to mediate binding to class II molecules and blockade of the groove, but this does not exclude additional contact sites for li. Using a set of overlapping li peptides and recombinant soluble li, we demonstrate here that a large segment of li encompassing approximately residues 71 to 128 interacts with HLA-DR molecules. The N- and C-terminal regions of this li segment appear to bind outside the peptide groove to the contact area for the staphylococcal superantigen Staphylococcus aureus enterotoxin B on the alpha 1 domain. The core region of this segment (residues 95-108) prevents binding of antigenic peptides, probably by interaction with the peptide groove. Occupation of the groove with antigenic peptides abolishes binding not only of the core region, but also that of those li peptides that bind outside the groove. These findings suggest the existence of distinct conformational states of class II molecules, with li binding preferentially to one form.


Subject(s)
Antigens, Differentiation, B-Lymphocyte/metabolism , HLA-DR Antigens/metabolism , Histocompatibility Antigens Class II/metabolism , Staphylococcus/immunology , Superantigens/metabolism , Amino Acid Sequence , Antigens, Differentiation, B-Lymphocyte/chemistry , Antigens, Differentiation, B-Lymphocyte/immunology , Base Sequence , Cell Line , Enterotoxins/chemistry , Enterotoxins/metabolism , HLA-DR Antigens/immunology , Histocompatibility Antigens Class II/chemistry , Histocompatibility Antigens Class II/immunology , Humans , Molecular Sequence Data , Protein Conformation , Recombinant Proteins/chemistry , Recombinant Proteins/immunology , Recombinant Proteins/metabolism , Superantigens/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...